Company news

Equillium, Inc. news in 2019

Equillium, Inc.'s news releases, calls and decks from 2019, newest first.

View company

Equillium Granted U.S. FDA Fast Track Designation for Itolizumab for the Treatment of Lupus Nephritis

December 8, 2019

Equillium Announces Leadership Updates

November 11, 2019

Equillium Announces Initiation of the EQUALISE Phase 1b Clinical Trial of Itolizumab for Patients with Lupus Nephritis and Provides Business Update

September 30, 2019

Decks in 2019